Recent Update on the Development of Leucine-Rich Repeat Kinase 2(LRRK2) Inhibitors: A Promising Target for the Treatment of Parkinson’sDisease

Ashish Patel(Charotar University of Science and Technology), Tushar Bambharoliya(North Carolina State University), Shyam Bhalodiya(Charotar University of Science and Technology), Dhruv Langaliya(Charotar University of Science and Technology), Meshwa Mehta(Maharaja Sayajirao University of Baroda), Stuti Patel(Charotar University of Science and Technology), Yug Patel(Charotar University of Science and Technology)
Medicinal Chemistry
February 16, 2022
Cited by 4


Related Papers